Search results

  1. Kidney conditions

    Everything NICE has said on kidney (renal) conditions in an interactive flowchart

  2. Osteoarthritis

    Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

  3. Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access (IPG710)

    Evidence-based recommendations on percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access in adults. This involves using

  4. Chronic kidney disease

    Everything NICE has said on chronic kidney disease in children, young people and adults in an interactive flowchart.

  5. Bladder cancer

    Everything NICE has said on bladder cancer in adults in an interactive flowchart

  6. Medicines optimisation

    Everything NICE has said on shared decision-making and processes to optimise medicines and support adherence in an interactive flowchart

  7. Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable (TA739)

    Evidence-based recommendations on atezolizumab (Tecentriq) for untreated PD-L1-positive locally advanced or metastatic urothelial cancer in adults when

  8. Chronic pain (primary and secondary)

    Everything NICE has said on assessing all chronic pain and managing chronic primary pain in people aged 16 years and over in an interactive flowchart.

  9. Postnatal care

    Everything NICE has said on postnatal care in an interactive flowchart

  10. Perioperative care

    Everything NICE has said on perioperative care in adults in an interactive flowchart.

  11. Atrial fibrillation

    Everything NICE has said on diagnosing and managing atrial fibrillation in an interactive flowchart

  12. Faltering growth

    Everything NICE has said on faltering growth in infants and children in an interactive flowchart

  13. Transition from children's to adults' services

    Everything NICE has said on the transition from children's to adults' services for young people in health or social care in an interactive flowchart

  14. Immunisations for under 19s

    Everything NICE has said on immunisation in under 19s in an interactive flowchart

  15. Cystic fibrosis

    Everything NICE has said on diagnosing and managing cystic fibrosis in an interactive flowchart

  16. Heavy menstrual bleeding

    Everything NICE has said on assessing and managing heavy menstrual bleeding in an interactive flowchart

  17. Looked-after children and young people (NG205)

    This guideline covers how organisations, practitioners and carers should work together to deliver high-quality care, stable placements and nurturing relationships for looked-after children and young people. It aims to help these children and young people reach their full potential and have the same opportunities as their peers.

  18. Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer (TA737)

    Evidence-based recommendations on pembrolizumab (Keytruda) with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and

  19. Berotralstat for preventing recurrent attacks of hereditary angioedema (TA738)

    Evidence-based recommendations on berotralstat (Orladeyo) for preventing recurrent attacks of hereditary angioedema in people 12 years and older

  20. Musculoskeletal conditions

    Everything NICE has said on musculoskeletal conditions in an interactive flowchart

  21. Oesophageal and gastric cancer

    Everything NICE has said on assessing and managing non-stromal oesophageal and gastric cancer in adults

  22. Upper aerodigestive tract cancer

    Everything NICE has said on assessing and managing upper aerodigestive tract cancer in young people and adults in an interactive flowchart

  23. Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (TA736)

    Evidence-based recommendations on nivolumab (Opdivo) for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chem

  24. Attention deficit hyperactivity disorder

    Everything NICE has said on diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults in an interactive flowchart

  25. Secukinumab for treating moderate to severe plaque psoriasis in children and young people (TA734)

    Evidence-based recommendations on secukinumab (Cosentyx) for moderate to severe plaque psoriasis in children and young people aged 6 to 17 years

  26. Psoriasis

    Everything NICE has said on psoriasis in an interactive flowchart

  27. Familial hypercholesterolaemia

    Everything NICE has said on familial hypercholesterolaemia in an interactive flowchart

  28. Patient experience in adult NHS services

    Everything NICE has said on improving the experience of care for people using adult NHS services in an interactive flowchart

  29. Influenza

    Everything NICE has said on influenza in an interactive flowchart

  30. Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia (TA733)

    Evidence-based recommendations on inclisiran (Leqvio) for treating primary hypercholesterolaemia or mixed dyslipidaemia in adults

  31. Cardiovascular disease prevention

    Everything NICE has said on cardiovascular risk assessment and modifying blood lipids for preventing cardiovascular disease in adults

  32. Depression

    Everything NICE has said on identifying, treating and managing depression in children, young people and adults in an interactive flowchart

  33. Lower limb peripheral arterial disease

    Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart

  34. Chest pain

    Everything NICE has said on assessing and diagnosing recent-onset chest pain of suspected cardiac origin and managing stable angina in an interactive flowchart

  35. Acute kidney injury

    Everything NICE has said on preventing, detecting and managing acute kidney injury in an interactive flowchart

  36. DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography (MTG60)

    Evidence-based recommendations on DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography

  37. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily.

  38. Suspected cancer recognition and referral

    Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart